You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-BRCA1 antibody [MS110] (ab16780)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab16780? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab16780 has been referenced in 6 publications.

  1. Kaira K et al. Prognostic significance of thymidylate synthase expression in the adjuvant chemotherapy after resection for pulmonary metastases from colorectal cancer. Anticancer Res 31:2763-71 (2011). IHC; Human. PubMed: 21868518
  2. Keimling M et al. Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double-strand break-repair signaling pathways. FASEB J : (2011). PubMed: 21778326
  3. Chène P et al. Catalytic inhibition of topoisomerase II by a novel rationally designed ATP-competitive purine analogue. BMC Chem Biol 9:1 (2009). IP; Human. PubMed: 19128485
  4. Geoffroy-Siraudin C et al. Meiotic abnormalities in patients bearing complete AZFc deletion of Y chromosome. Hum Reprod 22:1567-72 (2007). ICC/IF; Human. PubMed: 17428878
  5. Wilson CA et al. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet 21:236-40 (1999). PubMed: 9988281
  6. Scully R et al. Location of BRCA1 in human breast and ovarian cancer cells. Science 272:123-6 (1996). PubMed: 8600523

Publishing research using ab16780? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"